A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of E2007 [perampanel] in patients with painful diabetic neuropathy.
Phase of Trial: Phase II/III
Latest Information Update: 12 Sep 2014
At a glance
- Drugs Perampanel (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- 19 Aug 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 19 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Dec 2008 Status changed from recruiting to active, no longer recruiting.